EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eris Lifesciences's enterprise value is ₹133,293 Mil.
Eris Lifesciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹19,913 Mil. Therefore, Eris Lifesciences's EV-to-Revenue for today is 6.69.
The historical rank and industry rank for Eris Lifesciences's EV-to-Revenue or its related term are showing as below:
BOM:540596'
s EV-to-Revenue Range Over the Past 10 Years
Min: 4.67 Med: 6.96 Max: 13.83
Current: 6.69
During the past 12 years, the highest EV-to-Revenue of Eris Lifesciences was 13.83. The lowest was 4.67. And the median was 6.96.
BOM:540596's EV-to-Revenue is ranked worse than 82.7% of 1023
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs BOM:540596: 6.69
The historical data trend for Eris Lifesciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eris Lifesciences's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eris Lifesciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Eris Lifesciences's EV-to-Revenue falls into.
Eris Lifesciences's current Enterprise Value is ₹133,293 Mil.
Eris Lifesciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹19,913 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eris Lifesciences's share price for today is ₹878.40.
Eris Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹146.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eris Lifesciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Eris Lifesciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Eris Lifesciences (BOM:540596) Business Description
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:540596 has been successfully added to your 